In patients with migraine, it is theorized that the trigeminal nerve axons are abnormally activated, leading to the release of neurotransmitters including calcitonin gene-related peptide (CGRP) and substance P (SP), neurokinin A, and nitrous oxide. The gene discussed is TAC1; the disease is migraine disorder.